The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II/III trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed glioblastoma (GBM) patients with MGMT promoter hypermethylation (Alliance A071102).
 
Jann Nagina Sarkaria
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Travecta Therapeutics
Research Funding - Abbvie; AstraZeneca; Bayer; Black Diamond Therapeutics; Boehringer Ingelheim; Boston Scientific; Bristol-Myers Squibb/Celgene; FORMA Therapeutics; GlaxoSmithKline; Karyopharm Therapeutics; Wayshine Biopharma
 
Karla V. Ballman
Consulting or Advisory Role - Agenus; Medtronic; Takeda
Patents, Royalties, Other Intellectual Property - Prostate cancer signature patent (Inst)
Expert Testimony - Janssen Oncology; Janssen Oncology; Lilly; Sanofi
 
Sani Haider Kizilbash
Research Funding - Apollomics (Inst); Celgene (Inst); Incyte (Inst); Loxo (Inst); Nerviano Medical Sciences (Inst); Orbus Therapeutics (Inst); Wayshine Biopharma (Inst)
 
Erik P. Sulman
Honoraria - Novocure; Zai Lab
Research Funding - Novocure (Inst)
 
Caterina Giannini
No Relationships to Disclose
 
Sandeep H. Mashru
No Relationships to Disclose
 
David Eric Piccioni
No Relationships to Disclose
 
Bret Edward Buckley Friday
No Relationships to Disclose
 
Jesse G. Dixon
No Relationships to Disclose
 
Brian Kabat
No Relationships to Disclose
 
Nadia N. Laack
Research Funding - Bristol Myers Squib (Inst)
 
Leland Hu
Patents, Royalties, Other Intellectual Property - US Patent Applications: 15/290,963; PCT/US2018/061887; PCT/US2019/019687
 
Priya Kumthekar
Stock and Other Ownership Interests - EnClear Therapies; Vivacitas Oncology
Consulting or Advisory Role - Affinia Therapeutics; Biocept; BioClinica; ElevateBio; EnClear Therapies; Janssen; Novocure; Orbus Therapeutics; SDP Oncology; Sintetica
Research Funding - Angiochem; DNAtrix; Genentech; Novocure; Orbus Therapeutics
Patents, Royalties, Other Intellectual Property - Utility patent for ANG 1005. No financial gain, no royalties.
 
Benjamin M. Ellingson
Consulting or Advisory Role - Alpheus Medical; Chimerix; Ellipses Pharma; Global Coalition for Adaptive Research; Imaging Endpoints; ImmunoGenesis; Janssen; Kazia Therapeutics; Medicenna; MedQIA; Monteris Medical; Neosoma; SERVIER; Siemens; Sumitomo Dainippon Pharma Oncology; VBL Therapeutics
Research Funding - Janssen; Siemens
Travel, Accommodations, Expenses - Siemens
 
S. Keith Anderson
No Relationships to Disclose
 
Evanthia Galanis
Consulting or Advisory Role - Agios (Inst); Gradalis; Karyopharm Therapeutics (Inst); MedImmune (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); MedImmune (Inst); TRACON Pharma (Inst)